Dr. Bernardi is a chief fellow in the department of pediatrics, section of hematology-oncology, Baylor College of Medicine. He studies cancer pharmacology, experimental therapeutics and drug development. He has been researching the identification and evaluation of novel therapeutic targets for medulloblastoma, including the use of shRNA genetic screens.